Retrieved from Poudel, P., & Lappin, S
Unlike many peptide-based compounds that require specialized delivery systems (such as injectable carriers) or are rapidly broken down by digestive enzymes, BPC-157's inherent resistance to hydrolysis and enzymatic digestion allows for its potential oral administration
This is a valid option, especially for microdosing protocols where you need very precise measurements of small doses
FDA-approved peptides (Saxenda, Wegovy, Zepbound) cause gastrointestinal side effects like nausea, vomiting and diarrhea in up to 80% of patients, with rare serious events including gallstones or inflammation of the pancreas
Low levels cause persistent fatigue that rest doesn't fix
Learn More Custom Add-Ons Many of our nutrients can be added to certain services to customize results and benefits